Evidence map›Paper›PMID 41756988›Full record

ArticlebioRxiv : the preprint server for biology2026

VDJdive and ECLIPSE enhance single-cell TCR sequencing analysis through the probabilistic resolution of ambiguous clonotypes.

Ethan C Burns, Mercedeh Movassagh, Jill F Lundell, Mingzhi Ye, Zhaochen Ye, Giacomo Oliveira, Rishabh Rout, Miya B Hugaboom, Kelly Street, David A Braun

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ethan C BurnsDepartment of Immunobiology, Yale School of Medicine, New Haven, CT, USA.ORCID 0009-0009-8061-3686
Mercedeh MovassaghDepartment of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-7690-0230
Jill F LundellHarvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0002-6048-4700
Mingzhi YeDivision of Biostatistics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Zhaochen YeCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.ORCID 0009-0000-4422-3861
Giacomo OliveiraDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0001-7435-5603
Rishabh RoutCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.ORCID 0009-0003-9921-9773
Miya B HugaboomCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-8099-3564
Kelly StreetDivision of Biostatistics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0001-6379-5013
David A BraunCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-4543-5553

Funding

Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI Eric P. Winer · 1985 to 2026
$85.0M
Statistical Methods for Integrative Genomics in CancerP01CA196569 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI David V Conti · 2016 to 2026
$25.5M
INTERDISCIPLINARY IMMUNOLOGY TRAINING PROGRAMT32AI007019 · NIAID · YALE UNIVERSITY · PI Carrie L. Lucas, David G. Schatz · 1985 to 2026
$14.4M
Tumor and immune determinants of effective anti-tumor immunity in renal cell carcinomaR37CA279822 · NCI · YALE UNIVERSITY · PI David Braun · 2023 to 2026
$2.6M
NCI NIH HHS P01 CA196569NCI NIH HHS P30 CA016359NCI NIH HHS R37 CA279822NIAID NIH HHS T32 AI007019
6 · The paper itself

Abstract

Single-cell T cell receptor sequencing (scTCR-seq) has transformed our ability to track individual T cell clones and has been instrumental in advancing our understanding of human T cell differentiation. However, current computational pipelines for analysis, which require precise matching of CDR3 sequences from exactly 2 heterodimeric TCR chains to define the clonotype for each cell, are inherently limited because of the substantial proportion of cells possessing "ambiguous" clonotypes driven by missing (undetected from the technical issue of chain "dropout") or extra chains (present from either true biological expression or due to technical artifacts such as cellular doublets and ambient TCR contamination). As a result, clone sizes are artificially reduced, impeding the tracking of clones across conditions and differentiation states. Here we introduce VDJdive and ECLIPSE (Enhanced CLonotypic Inference via Prediction of Single-cell Expression), two computational methods that, together, resolve this clonal ambiguity by utilizing the expectation-maximization algorithm for the clonal prediction of ambiguous cells. These methods consider chain pairings across the sample, allowing for high-fidelity prediction of chains lost due to dropout and the discernment of biological expression of extra chains from technical artifacts. Consequently, clone sizes are augmented and cells without clonotype assignments are minimized. Our approach facilitates enhanced clonal tracking through these elevated clone sizes and is easily implementable, compatible with standard single-cell transcriptomic workflows, and broadly applicable across biological contexts and T cell subsets.

Identifiers

PMID41756988
PMCPMC12934754

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.